I agree that this site is using cookies. You can find further informations here.
X
Nosaki, Kaname
83  results:
Search for persons X
?
1

Clinical outcomes in patients with non-small cell lung canc..:

Okahisa, Masanobu ; Udagawa, Hibiki ; Matsumoto, Shingo...
Lung Cancer.  191 (2024)  - p. 107798 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Unrealistic expectations and disclosure of incurability in ..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
Supportive Care in Cancer.  32 (2024)  7 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
3

Prognostic value of predominant subtype in pathological sta..:

Kitagawa, Shingo ; Zenke, Yoshitaka ; Taki, Tetsuro...
Lung Cancer.  188 (2024)  - p. 107453 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Corrigendum to "A phase II study (WJOG12819L) to assess the..:

Takeda, Masayuki ; Shimokawa, Mototsugu ; Nakamura, Atsushi...
Lung Cancer.  193 (2024)  - p. 107852 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Phase 2 trial of crizotinib in Japanese patients with advan..:

Nosaki, Kaname ; Yoh, Kiyotaka ; Toyozawa, Ryo...
International Journal of Clinical Oncology.  29 (2024)  8 - p. 1142-1151 , 2024
Link: https://doi.org/10.1007/..
 
?
6

A phase II study (WJOG12819L) to assess the efficacy of osi..:

Takeda, Masayuki ; Shimokawa, Mototsugu ; Nakamura, Atsushi...
Lung Cancer.  177 (2023)  - p. 44-50 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Prognostic impact and gene expression analysis of peri‐tumo..:

Kagawa, Yosuke ; Nakai, Tokiko ; Taki, Tetsuro...
Cancer Science.  114 (2023)  8 - p. 3423-3432 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Clinicopathological significance of peritumoral alveolar ma..:

Tanaka, Yu ; Nakai, Tokiko ; Suzuki, Ayako...
Cancer Immunology, Immunotherapy.  72 (2023)  7 - p. 2205-2215 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Large-scale clinico-genomic profile of non-small cell lung ..:

Tamiya, Yutaro ; Matsumoto, Shingo ; Zenke, Yoshitaka...
Lung Cancer.  176 (2023)  - p. 103-111 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Elements of End-of-Life Discussions Associated With Patient..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
The Oncologist.  29 (2023)  2 - p. e282-e289 , 2023
Link: https://doi.org/10.1093/..
 
?
11

Clinicogenomic Features and Targetable Mutations in NSCLCs ..:

Sakai, Tetsuya ; Matsumoto, Shingo ; Ueda, Yasuto...
Journal of Thoracic Oncology.  18 (2023)  11 - p. 1538-1549 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Prognostic Awareness and Discussions of Incurability in Pat..:

Hasegawa, Takaaki ; Okuyama, Toru ; Uemura, Takehiro...
The Oncologist.  27 (2022)  11 - p. 982-990 , 2022
Link: https://doi.org/10.1093/..
 
?
13

The impact of tertiary lymphoid structures on clinicopathol..:

Tamiya, Yutaro ; Nakai, Tokiko ; Suzuki, Ayako...
Lung Cancer.  174 (2022)  - p. 125-132 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Phase II study of atezolizumab with bevacizumab for non-squ..:

Seto, Takashi ; Nosaki, Kaname ; Shimokawa, Mototsugu...
Journal for ImmunoTherapy of Cancer.  10 (2022)  2 - p. e004025 , 2022
Link: https://doi.org/10.1136/..
 
?
15

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC ..:

Ninomiya, Kiichiro ; Teraoka, Shunsuke ; Zenke, Yoshitaka...
JTO Clinical and Research Reports.  2 (2021)  1 - p. 100107 , 2021
Link: https://doi.org/10.1016/..
 
1-15